Price history
¥3,452Latest+16.0%
Drag across the chart to measure the move between two points.Delayed 15 minutes · monthly closing basis
Business overview
Recurring subjects
No threads yetThis company's filings have not been read yet. We are adding them progressively.
Companies sharing a theme
News
Key numbersShowing 8 of 18
PER
111.79How many years of earnings it would take to buy the stock. The market average is generally considered to be around 15.PBR
1.07How many times the company's net assets? Around 1x is generally considered a benchmark.ROE
1.0%Earning power. A figure above 10% is generally considered good.Dividend yield
0.0%The annual dividend as a percentage of the share price.Market capitalization
¥4.2tnShare price × number of shares. The value of the entire company.Equity ratio
63.2%The proportion of assets funded by money that does not have to be repaid.Operating margin
6.2%The percentage of revenue remaining from the company’s core business.Revenue growth (3 years)
7.8%The average annual growth in sales over the past three years.What to watch next
Bio-CDMO: More details on operations and the ramp-up of one of Japan's largest CDMO facilities at the Toyama site, scheduled to begin operations in FY2027
FY2027, based on the current planImpact HighLikelihood Medium
Bio-CDMO: Disclosure of an earlier-than-planned schedule or expanded orders for the second phase at the North American site, involving the addition of 8 tanks of the same size, currently expected in 2028
Expected in 2028, including the possibility of an earlier startImpact MediumLikelihood Low
Semiconductor materials: Progress in ramping up operations and achieving orders and pricing under the ¥170 billion growth investment plan through 2027, particularly in CMP and process chemicals
Through 2027Impact MediumLikelihood Medium
Information on utilization rates and contract renewals accompanying the expansion or continuation of long-term manufacturing contracts with Janssen, Regeneron and others
As announced, to be monitored through earnings briefings and contract disclosuresImpact MediumLikelihood Medium
Digital and medical IT: Progress in expanding adoption and monetization of SYNAPSE-related businesses and business digital transformation offerings, including 3DWorks, Revoria and IWpro
Through the next fiscal year's earnings cycleImpact LowLikelihood Low
What to watch next
Who owns itTop holders total 38.1%
Listed holders 38.1%Everyone else 61.9%
The Master Trust Bank of Japan, Ltd. (Trust Account)18.30%
株式会社日本カストディ銀行 (Trust Account)6.29%
STATE STREET BANK AND TRUST COMPANY 5050013.41%
Nippon Life Insurance Company2.81%
JP MORGAN CHASE BANK 3857811.45%
THE CHASE MANHATTAN BANK, N.A. LONDONSECS LENDING OMNIBUS ACCOUNT1.33%
STATE STREET BANK AND TRUST COMPANY 5051031.23%
MOXLEY & CO LLC1.17%
2 other listed holders2.15%
| Holder | Ownership (%) |
|---|---|
| The Master Trust Bank of Japan, Ltd. (Trust Account) | 18.30 |
| 株式会社日本カストディ銀行 (Trust Account) | 6.29 |
| STATE STREET BANK AND TRUST COMPANY 505001 | 3.41 |
| Nippon Life Insurance Company | 2.81 |
| JP MORGAN CHASE BANK 385781 | 1.45 |
| THE CHASE MANHATTAN BANK, N.A. LONDONSECS LENDING OMNIBUS ACCOUNT | 1.33 |
| STATE STREET BANK AND TRUST COMPANY 505103 | 1.23 |
| MOXLEY & CO LLC | 1.17 |
| 2 other listed holders | 2.15 |
This company's documents
Filings
Timely disclosures
- 2026-09-09Notice Concerning the Transfer of Certain Businesses in the Graphic Communications Business
- 2026-08-06Notice Regarding the Commencement of Consideration of Strategic Options, Including a Partial Spin-off, to Achieve Sustainable Growth of the Business Innovation Business
- 2026-08-06Summary of Financial Results for the First Quarter of the Fiscal Year Ending March 2027 [U.S. GAAP] (Consolidated)
- 2026-07-24Notice Regarding Completion of Payment for the Disposal of Treasury Shares as Restricted Stock Compensation
- 2026-06-26Notice Concerning the Disposal of Treasury Shares as Restricted Stock Compensation
- 2026-05-29Notice of Convocation of the 2026 Annual General Meeting of Shareholders: Matters Omitted from the Documents Delivered
- 2026-05-29Notice of Convocation of the 2026 Annual General Meeting of Shareholders
- 2026-05-12Summary of Financial Results for the Fiscal Year Ending March 2026 [U.S. GAAP] (Consolidated)
Threads
- 2026-10-27Higher-Capacity Magnetic Tape and the Expansion of Long-Term Storage Services
- 2026-10-27Expanding Instant Prints with the Digitally Enabled instax SQUARE
- 2026-10-20Ensuring Profitability and Sustaining Growth in the High-Performance Materials Business
- 2026-09-29Cloud and Mobile-Enabled Solution Services
- 2026-09-20Fine and forfeiture of the match imposed for Fujifilm Ebina Minerva AFC's failure to participate in an official match
- 2026-09-18Strengthening Priority Businesses and Creating New Businesses through Integration of Foundational Technologies
- 2026-09-09Portfolio Shift Toward Digital Printing and Inkjet
- 2026-08-06Expansion into a Total Healthcare Company
101 more
- 2026-08-06Double-digit annual growth in medical IT, endoscopy and ultrasound diagnostics
- 2026-08-06Document growth centered on global services and production services
- 2026-08-06Clinical Support Solution Using an Integrated Medical IT Archive
- 2026-08-06Expansion of the iPS Cell and Regenerative Medicine Business
- 2026-08-06Dividends and Share Buybacks Linked to Growth Investment
- 2026-08-06Expansion of biopharmaceutical CDMO production capacity and development sites
- 2026-08-06Expansion of High-Value-Added Cameras through Medium-Format Mirrorless Cameras and the X Series
- 2026-08-06Transforming the Document Business Through the Acquisition of a 50.1% Stake in Xerox
- 2026-08-06Structural Reforms at Fuji Xerox Through the Reorganization of Sales, Production and Head-Office Functions
- 2026-08-06Declining Imaging Solutions sales and profit, and the rollout of high-value-added products
- 2026-08-06A World TOP Tier Business Portfolio Focused on Profitability and Capital Efficiency under VISION2030
- 2026-08-06Full-scale entry into the video production market with cameras for video production
- 2026-06-26Performance-linked compensation tied to consolidated net sales and consolidated operating profit
- 2026-06-24Expansion of Growth Areas through Strategic M&A
- 2026-06-24Strengthening Shareholder Returns and Improving Capital Efficiency Through Share Repurchases
- 2026-06-24Reducing Environmental Impact Across the Product Life Cycle
- 2026-06-24Policy Changes in Europe, the United States and Emerging Markets and Geopolitical Risks
- 2026-06-24Review of the Necessity and Economic Rationale of Strategic Shareholdings
- 2026-06-24Business and Supply Chain Impacts of the Global COVID-19 Pandemic
- 2026-06-24Provision and Increased Production of COVID-19 Response Products and Services
- 2026-06-24Securing funds for growth investment through business portfolio and cash flow management
- 2026-06-24Transition and physical risks arising from decarbonization policies and extreme weather
- 2026-06-24FUJIFILM Group Health and Productivity Management Declaration and Employee Health Promotion
- 2026-06-24Deploy medical AI technology in all 196 countries and regions by fiscal 2030
- 2026-06-24Improving the Percentage of Foreign-National Employees and Women in Management
- 2026-06-24Structuring DX Talent Development
- 2026-06-24Global Employee Engagement Surveys and Improvement
- 2026-06-24Contribution to cumulative CO2 emissions reductions in society
- 2026-06-24Expanding Access to Healthcare in Emerging Markets through NURA Health Screening Centers
- 2026-05-29Strengthening the Corporate Governance Framework Based on the Corporate Governance Guidelines
- 2026-05-29Board Oversight and Faster Business Execution through the Executive Officer System
- 2026-05-29Strengthening CSR Management, Compliance and Risk Management
- 2026-05-29Capturing demand for instant printing through smartphone connectivity
- 2026-05-29Creating Value to Address Social Issues through the FUJIFILM Sustainable Value Plan 2030
- 2026-05-12Business Portfolio Restructuring and Financial Targets under VISION2023
- 2026-05-12Group Purpose: “Increasing the number of smiles on Earth.”
- 2026-05-12Strengthening the supply system through joint procurement with Konica Minolta
- 2025-11-14Informatics Research Utilizing IoT and AI
- 2025-11-14Impact of Overseas Operations and Foreign Exchange Fluctuations on Performance
- 2025-11-14Global business foundation with approximately 60% of sales generated overseas
- 2025-11-14Business composition by three business solutions
- 2025-11-14Entry into Contract Testing Services for In Vitro Diagnostics (IVD) and Veterinary Specimens
- 2025-11-14Expansion of In Vitro Diagnostics (IVD) and Digital X-ray Diagnostic Products
- 2025-06-25Improving Productivity and Profitability by Halving Lead Times
- 2025-06-25Rebuilding Group Governance Following Fuji Xerox's Improper Accounting
- 2025-06-25Decline in Profit Before Tax and Net Income Due to Impairment Losses on Equity Securities
- 2025-06-25Securing, Developing and Retaining Highly Specialized Talent
- 2025-06-25Bio-CDMO Financing Through Social Bonds
- 2025-06-25Company-wide DX Initiatives Led by the DX Strategy Council
- 2024-11-14Expansion of Global Market Share for 4K Broadcast Zoom Lenses
- 2024-06-28Intensifying Competition, Shorter Product Life Cycles and Substitute Products
- 2024-06-28“Hibimikke” (AI Crack-Detection Service): Social Infrastructure Inspection Service Using AI Image Analysis
- 2024-06-28Improving Biopharmaceutical Manufacturing Efficiency Through an End-to-End Continuous Production System
- 2024-06-28Cross-Business Integration by the Life Sciences Strategy Headquarters and Life Sciences Business Division
- 2024-06-28¥1 trillion sales target for the Medical Systems business in FY2030
- 2024-06-28Sale of the Electronic Medical Records and Medical Claims-Related Business
- 2024-06-28Broadening the investor base through a stock split
- 2024-02-14Expanding the Life Sciences Business Through the Renewal of High-Performance Cosmetics
- 2024-02-14Application of an Allowance for Credit Losses Based on the Expected Credit Loss Model
- 2023-08-14Business Expansion into Touch Panels, Environmental Energy and Other Areas
- 2023-08-14Natural disasters, supply disruptions, equipment failures, and product defects
- 2023-08-14Entering the Surveillance Camera Market with a Long-Range Surveillance Camera
- 2023-06-30New Entry into the Projector Market with Projectors Equipped with FUJINON Lenses
- 2023-06-30Risk of Failure to Realize Acquisition Benefits, Integration Delays and Goodwill Impairment
- 2023-06-30Provide Workstyle Solutions to 50 Million People
- 2023-06-30Reduction in Water Intake
- 2023-06-30Carbon-Negative Technology through CO2 Valorization
- 2023-06-30M&A Investment Committee Selection of Opportunities and PMI Management
- 2022-06-30Pipeline Development for Anticancer Drugs, Dementia Treatments, etc.
- 2022-06-30Profit contribution from new businesses, global expansion and efficient management
- 2022-06-30Expanding the Photo Printing Market through Value-Added Printing Services
- 2022-06-30Integration of Toyama Chemical and FUJIFILM RI Pharma
- 2022-06-30Investment in Biotech Startups through LS-CVC
- 2021-06-30Information System Disruptions and Personal Information Leaks
- 2021-06-30Creation of New Businesses Through Patent Licensing
- 2021-06-30Expansion of Infection-Control Products Using Hydro Ag+ Antibacterial Technology
- 2021-06-30Product Defects, Product Liability and Product Accidents
- 2021-06-30Research and Development Delays, Failure to Obtain Approval, and Post-Marketing Safety Issues
- 2020-08-14One-Time Expenses Arising from Structural Reforms
- 2020-06-29Business Structural Transformation Away from Dependence on Photographic Film and Entry into a New Growth Phase
- 2020-06-29Deepening the Business Portfolio in Three Stages and Making a Strategic Leap through VISION2019
- 2020-06-29VISION2019 Financial Targets for Fiscal 2019
- 2020-06-29Development of a DDS manufacturing platform through a new plant dedicated to liposomal formulations
- 2019-11-14Policy for Responding to Acquisition Proposals to Protect Corporate Value and the Common Interests of Shareholders
- 2019-11-14Enhancing Corporate Value through Diverse Technological Capabilities, a Global Network, Talent and Corporate Culture
- 2019-11-14AI personalization through the FUJIFILM PhotoBank photo cloud service
- 2019-11-14Application of Lease Accounting Standards and Recognition of Right-of-Use Assets and Liabilities
- 2019-08-14Pharmacist workflow support using the PROOFIT 1D unit-dose packaging verification support system
- 2019-08-14Full-scale entry into the endoscopic surgical instruments business
- 2019-06-28Adoption of the New Revenue Recognition Standard and Deduction of Sales Promotion Expenses from Net Sales
- 2018-08-14Co-creating value with external partners through the Open Innovation Hub
- 2018-06-29Inappropriate Accounting Practices and Transactions at Fuji Xerox’s Overseas Subsidiaries
- 2018-06-29Contract manufacturing services for specialty chemicals using flow synthesis
- 2018-06-29Anti-counterfeiting and authentication services using Yoctrace (object-specific pattern recognition) technology
- 2017-08-14Realizing a Stable-Growth Portfolio through VISION2016
- 2017-08-14Business Portfolio with Healthcare, High-Performance Materials and Documents as Growth Drivers
- 2017-07-31Business Partnerships and Use of Sales Networks in the Chinese and Russian Markets
- 2017-07-31Standardization of 3D Printing Data Using FAV
- 2016-06-30Patent Expiration, Alternative Technologies, and Intellectual Property Litigation
- 2016-06-30Addressing Government Regulations and Laws in Each Country
- 2016-06-30Business Interruption Caused by Large-Scale Natural Disasters, Terrorism and Infectious Diseases